Microcap Ledger Do equity line announcements hurt microcap stocks? What 237 deals show
We tracked 237 equity line (ELOC) announcements by Nasdaq and NYSE American microcaps from 2021 to 2026. The first-day move was small. Six months later, the typical stock was down by more than half.
- Study period
- January 2021 to October 2026 (prices to the Oct 12, 2026 close)
- Sample
- 237 announcements by 204 companies
The short version
- The announcement itself barely moved prices: the median stock fell 1.1% from the prior close to the first session's close, and 41% rose.
- The declines came later. The median return was −11% after 20 trading days, −35% after 60 and −55% after 120. 89% of stocks were lower after 120 days. Small caps as a whole (IWM) were up about 2.5% over the same windows.
- Share counts climbed fast. The median company had 48% more shares about six months later and 220% more about a year later (split-adjusted, all issuance).
- Most facilities were barely used. In a subsample of 90, the median company drew 7% of the headline amount in the first year, and 63% drew less than 10%.
- The pattern held in every year, for every major investor and whatever the 8-K said the money was for. Firms that sign these deals are usually short of cash (81% carried a going-concern warning), so the study shows what followed, not what caused it.
Equity lines don’t usually knock a microcap down on the day they’re announced. The damage, in this sample, came afterwards. We tracked 237 new equity line (ELOC) facilities announced by Nasdaq and NYSE American companies worth under $300 million from January 2021 to October 2026. The median stock was down 1% after the first session, 11% after a month of trading, 35% after three months and 55% after six. Only about one in ten was higher after 120 trading days.
That’s history, not a forecast, and it isn’t proof that the equity line caused the fall. Companies sign these deals because they need cash: 81% of this sample carried a going-concern warning in their latest 10-K or 10-Q. We can show what usually followed. We can’t separate the facility from the situation that led to it.
How an equity line works
An equity line is a commitment from one investor to buy up to a set dollar amount of a company’s shares over time, when the company asks, usually at a discount to recent prices. The investor normally resells those shares in the market. Our equity line explainer covers the mechanics. For the related tools, see ATM offerings and how dilution works.
The median facility here was $25 million, against a median market cap of $17.9 million. Half the facilities were larger than 117% of the company’s market value.
What happened to the stock
Median return after an equity line announcement
Chart data
| Median return | Median vs IWM | Events | |
|---|---|---|---|
| +1 day | −1.1% | −1.1% | 237 |
| +5 | −3.5% | −4.1% | 236 |
| +20 | −11.3% | −13.8% | 233 |
| +60 | −34.6% | −35.7% | 221 |
| +120 | −54.5% | −56.9% | 212 |
The first-day reaction was mixed: 41% of stocks rose. The decline then built steadily. Against small caps as a whole the picture is the same. IWM rose a median 2.5% over the 120-day windows, so the abnormal return at day +120 was −57%.
The spread is wide. The 10th percentile at day +60 was −71%, the 90th was +19%, and five stocks more than doubled.
Spread of 60-day returns
Chart data
| Range | Events |
|---|---|
| −100% to −80.0% | 15 |
| −80.0% to −60.0% | 35 |
| −60.0% to −40.0% | 51 |
| −40.0% to −20.0% | 43 |
| −20.0% to 0.0% | 40 |
| 0.0% to +20.0% | 15 |
| +20.0% to +40.0% | 4 |
| +40.0% to +60.0% | 6 |
| +60.0% to +80.0% | 6 |
| +80.0% to +100% | 6 |
Did size, investor or purpose matter?
Less than you might expect. The facilities biggest relative to the company, over three times market cap, had the worst median 60-day return at −48%. But every size band was down by about 30% or more, and the 17 smallest facilities (under a quarter of market cap) were down 41%. There’s no clean line from size to outcome.
60-day return by facility size relative to market cap
Chart data
| Median +60-day return | Median vs IWM | Events | |
|---|---|---|---|
| Under 25% of market cap | −41.2% | −42.2% | 17 |
| 25% to 100% | −32.2% | −32.9% | 88 |
| 100% to 300% | −30.2% | −33.4% | 55 |
| Over 300% | −47.9% | −50.9% | 59 |
By investor, median 60-day returns ranged from −29% (Arena, 8 deals) to −57% (Hudson Global Ventures, 5 deals). The two biggest names were Lincoln Park (55 deals, −32%) and Yorkville (37 deals, −40%). These groups are small, and different investors work with different kinds of companies.
What the 8-K said the money was for made little difference: −37% for “working capital and general corporate purposes”, −34% where a specific use was named and −34% where none was stated.
60-day return by stated use of the money
Chart data
| Median +60-day return | Median vs IWM | Events | |
|---|---|---|---|
| General / working capital | −36.5% | −34.0% | 78 |
| Specific use named | −33.8% | −39.0% | 41 |
| Not stated | −34.1% | −35.1% | 102 |
Going-concern status did line up with outcomes. Companies with a warning had a median 60-day return of −40%; the 45 without one were at −28%. Every calendar year from 2021 to 2026 had a negative median, from −29% in 2022 to −55% for the 15 deals from 2026 with 60 days of data so far.
The share count
The median company had 48% more shares about six months after the announcement and 220% more about a year after, adjusted for reverse splits. A third had at least six times as many shares a year later. These counts include every source of new stock: the equity line, other offerings, note conversions, warrant exercises and mergers.
Announcement vs actual use
The investor can’t buy until a resale registration covering the shares is effective. For 158 events we matched a resale registration that names the investor and its SEC effectiveness notice. It went effective a median 40 days after the announcement. From that date, the median stock fell 0.4% in the first session, 16% after 20 sessions and 42% after 60.
Returns from the announcement vs from the resale registration going effective
Chart data
| From announcement | From registration effective | Events | |
|---|---|---|---|
| +1 day | −0.8% | −0.4% | 157 |
| +5 | −4.4% | −4.5% | 157 |
| +20 | −10.2% | −16.4% | 155 |
| +60 | −34.4% | −41.7% | 146 |
| +120 | −63.0% | −55.4% | 134 |
Actual draws show up later, in 10-Q and 10-K disclosures. For a subsample of 90 facilities announced by June 2025, we pulled the amounts sold to the investor over roughly the first year. This is a subsample and the figures are estimates.
| Usage in the first ~12 months (90 facilities) | Count | Share |
|---|---|---|
| Drew under 1% of the commitment | 20 | 22% |
| Drew under 10% | 57 | 63% |
| Drew 50% or more | 6 | 7% |
| Median drawn | 7% |
Quarter by quarter, the 56 quarters with heavy draws (at least 5% of the announcement-day market cap) had a median stock return of −44% and median share-count growth of 34%. The 162 quarters with no draws had −24% and 10%. Read this with care. Companies tend to draw when there’s trading volume to sell into, and a falling price means more shares for each dollar raised, so the direction of cause runs both ways.
The headline commitment is a cap, not money raised. In most of these cases the stock fell a long way while the company used only a small part of its line.
The outliers
Returns from the prior close to day +60. Context is what the company filed in the window, not a claim about why the stock moved.
| Company | Announced | Investor, size | Mkt cap | +60 days | Filed in the window |
|---|---|---|---|---|---|
| Agrify (AGFY, now RYTHM) | Aug 29, 2024 | Ionic Ventures, $15M | $3.5M | +1,181% | 1-for-15 reverse split, Oct 2024; note financing and management changes, Nov 2024 |
| Nukkleus (NUKK, now T3 Defense) | Dec 6, 2024 | YA II PN, $10M | $24.9M | +859% | Agreement to buy 51% of Star 26, a defense supplier, Dec 17, 2024 |
| Enochian Biosciences (ENOB) | Jun 27, 2023 | Lincoln Park, $20M | $26.8M | +637% | $1.3M private placement at $0.53, Jun 2023; Series A preferred, Aug 2023 |
| Augmedix (AUGX) | Apr 20, 2023 | RedCo II Master Fund, $5M | $67.5M | +126% | New statements of work with CommonSpirit Health, May 2023 |
| Plus Therapeutics (PSTV) | Jun 20, 2025 | Lincoln Park, $50M | $6.3M | +119% | Nasdaq listing hearing updates, Aug 2025; no deal 8-K found |
| Vivakor (VIVK) | May 14, 2026 | Investor not named, $100M | $3.0M | −95% | Several unregistered share sales; 1-for-20 reverse split, Jul 2026 |
| Mullen Automotive (MULN) | May 24, 2024 | Investor not named, $150M | $49.8M | −94% | Settlement letting an investor exchange claims for shares, Jun 2024 |
| Crown Electrokinetics (CRKN) | Oct 15, 2024 | Liqueous, $100M | $5.9M | −93% | Nasdaq listing notice, Dec 2024 |
| KIDZ AI (KIDZ) | May 22, 2026 | Chardan, $100M | $0.5M | −93% | Note financing, May 2026; 1-for-10 reverse split, Jun 2026 |
| Nuvve (NVVE) | Nov 14, 2025 | Investor not named, $25M | $16.0M | −93% | Private placements, Nov to Dec 2025; reverse split amendment, Dec 2025 |
Price returns are split-adjusted, so a reverse split doesn’t count as a gain or a loss.
Caveats
Delisted names aren’t missing. A stock’s history stops when it leaves its exchange, and we include every event up to that point (see the method). The sample covers deals announced in an 8-K. Facilities that only appeared in a prospectus or a 10-Q aren’t included. Market caps use the latest cover-page share count, which can lag a recent issuance.
The full event list, with every return and classification, is in the CSV download.
How we did it
Sample. We searched SEC EDGAR full-text search for 8-Ks filed from January 2021 to October 2026 that report Item 1.01 and mention an equity line, a common stock purchase agreement, an equity purchase agreement, a committed equity facility or a known equity line investor (White Lion, Yorkville/YA II PN, Lincoln Park, B. Riley Principal Capital, Keystone, Arena, Tumim Stone and others). That gave 5,700 filings. We kept companies whose cover page lists Nasdaq or NYSE American, read each Item 1.01 with an AI model, kept new common-stock facilities (not amendments, renewals, ATMs, notes-only or preferred-only deals) and checked borderline cases by hand. Filings by the same company within 30 days, or with the same investor within 120 days, count as one facility. 315 facilities qualified. We dropped 14 with no exchange price history, 41 with no recent cover-page share count, 19 with a market cap of $300 million or more (our microcap cutoff), 3 SPACs and one facility signed by Onfolio Holdings (see below). That left 237.
Event day and returns. The event day is the first trading session at or after the 8-K's EDGAR acceptance time; filings accepted after 4pm Eastern count from the next session. Returns run from the prior session's close. Prices are Alpaca Markets daily bars (SIP feed, split-adjusted). Abnormal returns subtract IWM (we also checked IWC, which gives the same picture). We report medians because a few huge moves pull the means around.
Delisted names. Price history ends when a stock leaves its exchange. Four stocks stopped trading before day +120; we keep them where data exists. Carrying their last close forward changes the +120 median by less than one point. Recent announcements without 120 sessions of history are left out of the longer horizons only.
Splits and labels. Going-concern status comes from the latest 10-K or 10-Q filed before the 8-K. Use of proceeds is keyword-and-model classified; 111 of 237 filings (47%) didn't state a use. Share counts are dei:EntityCommonStockSharesOutstanding from XBRL, adjusted with Alpaca's split factors; counts within 10 days of a split are skipped.
Usage subsample. For 188 facilities announced by June 2025 we read the equity line disclosures in the next 15 months of 10-Qs and 10-Ks with an AI model and kept the 90 with a usable figure covering about a year. We capped totals at the commitment, kept cumulative totals from falling, and corrected figures reported in thousands. Hand checks found occasional errors (a later facility counted with the first, for example), so treat these as estimates.
The sample excludes Onfolio Holdings (ONFO), which owns Microcap Ledger.
The daily movers email
The biggest micro-cap moves and what's behind them, from the filings. Free, every trading day.
FAQ
- Does an equity line announcement make a stock fall?
- Not on the day, usually. In our 237 cases the median first-session move was −1.1%. The large declines came over the following weeks and months, as companies registered and sold shares. That timing fits dilution and selling, but it doesn't prove the facility caused the fall: most of these companies were already short of cash.
- How much of an equity line do companies actually use?
- Usually a small part. In a 90-facility subsample, the median company drew 7% of the headline commitment in the first year. Only 6 drew more than half. Headline sizes are caps, not money raised.
- Why measure from the resale registration date too?
- The investor can't buy, and the company can't draw, until the resale registration for those shares is effective. That date, a median 40 days after the announcement here, is when selling into the market can start.
Sources
- SEC EDGAR full-text search (8-K, Item 1.01, 2021 to 2026)
- SEC EDGAR submissions and XBRL APIs (filing times, share counts)
- Alpaca Markets historical stock bars (SIP, split-adjusted)
- Agrify 8-K, equity line with Ionic Ventures · 8-K · filed 2024-08-29
- Agrify 8-K, 1-for-15 reverse split · 8-K · filed 2024-10-04
- Nukkleus 8-K, agreement to acquire 51% of Star 26 · 8-K · filed 2024-12-17
- Enochian Biosciences 8-K, private placement at $0.53 · 8-K · filed 2023-06-28
- Augmedix 8-K, CommonSpirit statement of work · 8-K · filed 2023-05-09
- Plus Therapeutics 8-K, Nasdaq hearing update · 8-K · filed 2025-08-13
- Vivakor 8-K, 1-for-20 reverse split · 8-K · filed 2026-07-16
- Mullen Automotive 8-K, settlement agreement and charter amendment · 8-K · filed 2024-06-06
- Crown Electrokinetics 8-K, Nasdaq notice · 8-K · filed 2024-12-23
- KIDZ AI 8-K, 1-for-10 reverse split · 8-K · filed 2026-06-04
- Nuvve 8-K, reverse split amendment · 8-K · filed 2025-12-11